Discovery of VU0467485/AZ13713945: An M4 PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia

Overview of attention for article published in ACS Medicinal Chemistry Letters, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 3 X users

patent: 23 patents

Readers on

mendeley: 34 Mendeley

So far, Altmetric has seen 23 patents that reference this research output.

Compositions and methods for treating disorders ameliorated by muscarinic receptor…

Grant US-12558317-B2

United States of America

24 Feb 2026

ORGANIC COMPOUNDS AS MUSCARINIC M4 RECEPTOR POSITIVE ALLOSTERIC MODULATORS (M4 PAMS)

Application WO-2025134078-A1

World Intellectual Property Organisation (WIPO)

26 Jun 2025

PIPERIDINE SUBSTITUTED COMPOUNDS AS MUSCARINIC M4 RECEPTOR POSITIVE ALLOSTERIC MODULATORS …

Application WO-2025099660-A1

World Intellectual Property Organisation (WIPO)

15 May 2025

Compositions and methods for treating disorders ameliorated by muscarinic receptor…

Grant US-11890378-B2

United States of America

06 Feb 2024

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 19 additional patents.